Global Depyrogenated Sterile Empty Vials Market
Medical Equipment

Depyrogenated Sterile Empty Vials Market Projected To Surpass $5.54 Billion By 2030 At 7.9% CAGR

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Expansion Is Expected For The Depyrogenated Sterile Empty Vials Market Over The Forecast Period?

The depyrogenated sterile empty vials market size has experienced robust growth in recent years. It is anticipated to expand from $3.79 billion in 2025 to $4.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. This historical growth can be credited to rising injectable drug production volumes, expansion of sterile pharmaceutical manufacturing, increasing regulatory scrutiny on injectable safety, growth of biologics and vaccines, and adoption of borosilicate glass packaging.

The depyrogenated sterile empty vials market is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $5.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. The expansion projected for this period stems from factors such as a rise in demand for biologics and biosimilars, greater investments in aseptic fill-finish facilities, the widening scope of contract manufacturing services, an intensified focus on contamination management, and the increasing uptake of pre-sterilized packaging solutions. Key trends observed during the forecast period encompass a surge in the adoption of high-purity injectable packaging, a growing need for ready-to-fill vials, an elevated focus on endotoxin-free packaging criteria, the broadening of automated depyrogenation methods, and a heightened commitment to primary packaging that adheres to regulatory requirements.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8562&type=smp

Which Core Factors Are Supporting The Expansion Of The Depyrogenated Sterile Empty Vials Market?

The global increase in infectious diseases is projected to stimulate the growth of the depyrogenated sterile empty vials market. Infectious diseases are defined as conditions caused by detrimental microorganisms such as bacteria, viruses, parasites, and fungi. Depyrogenated sterile vials are essential for storing injectable medications used in the treatment of these diseases. Moreover, depyrogenated sterile empty vials also find application in collecting laboratory samples. As an illustration, in February 2024, the Health Security Agency, a UK government agency, reported that tuberculosis (TB) cases in England rose by 10.7% in 2023 compared to 2022. The case count ascended from 4,380 in 2022 to 4,850 in 2023. Thus, the escalating prevalence of infectious diseases worldwide will fuel the expansion of the depyrogenated sterile empty vials market.

How Is Segment Classification Applied In The Depyrogenated Sterile Empty Vials Market?

The depyrogenated sterile empty vials market covered in this report is segmented –

1) By Product: 2 ML, 5 ML, 10 ML, 20 ML, >20 ML

2) By Packaging: Glass, Plastic

3) By End User: Clinical Labs, Compounding Labs, Pharmaceutical Companies, Contract Manufacturing Organization, Distributors

What Trends Are Influencing The Depyrogenated Sterile Empty Vials Market Outlook?

Leading companies within the depyrogenated sterile empty vials market are concentrating on developing advanced products, such as deep-cold freeze vials, to address the increasing need for safer, more dependable biopharmaceutical storage and transport. These deep-cold freeze vials are specialized sterile containers designed for the secure storage of biological materials at extremely low temperatures (–80°C to –150°C). They serve to protect sensitive drugs, vaccines, and samples from degradation, maintain sterility, and ensure product stability during prolonged storage and transport. For example, in January 2024, SCHOTT Pharma AG & Co. KGaA, a Germany-based specialty glass manufacturing company, introduced EVERIC freeze vials, an innovative series of vials specifically engineered for mRNA and gene-therapy products that necessitate deep-cold preservation and high container integrity. The EVERIC freeze vials are Type I borosilicate glass containers manufactured and approved for use at ultralow temperatures; they incorporate strengthened glass geometry and process controls to limit breakage during freeze-thaw events, are compatible with standard lyophilization and cryogenic logistics, offer controlled dimensional accuracy for automated filling and capping lines, and are intended to reduce delamination/particulate risks and improve drug stability compared with conventional vials, making them suitable for vaccines, gene-therapy vectors, and other temperature-sensitive biologics.

Who Are The Companies Shaping The Depyrogenated Sterile Empty Vials Market Landscape?

Major companies operating in the depyrogenated sterile empty vials market are APG Pharma, Corning Inc., DWK Life Sciences, Nipro PharmaPackaging, Schott AG, Thermo Fisher Scientific, Gerresheimer AG, Stevanato Group, SGD Pharma, Merck KGaA, SiO2 Materials Science, Shandong Pharmaceutical Glass Co. Ltd., West Pharmaceutical Services Inc., Ompi Srl, Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging Limited, Acme Vial and Glass Company LLC, Amposan S.A., BMT Corporation, Cangzhou Four Stars Glass Co. Ltd., Zhejiang Pharmaceutical-Packaging Co. Ltd.

Access The Complete Depyrogenated Sterile Empty Vials Market Report:

https://www.thebusinessresearchcompany.com/report/depyrogenated-sterile-empty-vials-global-market-report

Which Region Leads The Depyrogenated Sterile Empty Vials Market By Size?

North America was the largest region in the depyrogenated sterile empty vials market in 2025. The regions covered in the depyrogenated sterile empty vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Depyrogenated Sterile Empty Vials Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8562&type=smp

Browse Through More Reports Similar to the Global Depyrogenated Sterile Empty Vials Market 2026, By The Business Research Company

Sterile Medical Packaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report

Sterile Compounding Pharmacies Market Report 2026

https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report

Generic Oncology Sterile Injectable Market Report 2026

https://www.thebusinessresearchcompany.com/report/generic-oncology-sterile-injectable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model